Your browser doesn't support javascript.
loading
The Evolving Role of Genetic Evaluation in the Prenatal Diagnosis and Management of Congenital Heart Disease.
Bucholz, Emily M; Morton, Sarah U; Madriago, Erin; Roberts, Amy E; Ronai, Christina.
Afiliación
  • Bucholz EM; Section of Cardiology, Department of Pediatrics, University of Colorado Denver, Denver, CO 80204, USA.
  • Morton SU; Division of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Madriago E; Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239, USA.
  • Roberts AE; Department of Cardiology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
  • Ronai C; Department of Cardiology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
J Cardiovasc Dev Dis ; 11(6)2024 May 30.
Article en En | MEDLINE | ID: mdl-38921669
ABSTRACT
Congenital heart disease (CHD) is increasingly diagnosed prenatally and the ability to screen and diagnose the genetic factors involved in CHD have greatly improved. The presence of a genetic abnormality in the setting of prenatally diagnosed CHD impacts prenatal counseling and ensures that families and providers have as much information as possible surrounding perinatal management and what to expect in the future. This review will discuss the genetic evaluation that can occur prior to birth, what different genetic testing methods are available, and what to think about in the setting of various CHD diagnoses.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Cardiovasc Dev Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Cardiovasc Dev Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos